IRIS UniCatt

Bianchi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.295
AS - Asia 4.530
EU - Europa 4.074
SA - Sud America 1.037
AF - Africa 125
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 15.079
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.104
SG - Singapore 2.057
DE - Germania 1.135
CN - Cina 985
BR - Brasile 835
IT - Italia 660
VN - Vietnam 609
SE - Svezia 521
FR - Francia 350
UA - Ucraina 252
PL - Polonia 247
GB - Regno Unito 197
IE - Irlanda 162
FI - Finlandia 158
IN - India 154
RU - Federazione Russa 137
JP - Giappone 136
ID - Indonesia 131
CA - Canada 96
HK - Hong Kong 91
AR - Argentina 81
MX - Messico 58
BD - Bangladesh 57
NL - Olanda 56
IQ - Iraq 43
TR - Turchia 43
AT - Austria 40
ZA - Sudafrica 37
BE - Belgio 30
ES - Italia 30
VE - Venezuela 27
EC - Ecuador 26
KR - Corea 26
PK - Pakistan 22
IR - Iran 21
CO - Colombia 20
AE - Emirati Arabi Uniti 18
EG - Egitto 18
UZ - Uzbekistan 18
MA - Marocco 16
SA - Arabia Saudita 15
CL - Cile 14
PY - Paraguay 13
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 12
KE - Kenya 12
KZ - Kazakistan 12
PE - Perù 12
RO - Romania 11
CH - Svizzera 10
AL - Albania 9
AZ - Azerbaigian 9
JO - Giordania 9
PT - Portogallo 9
LB - Libano 8
LT - Lituania 8
DO - Repubblica Dominicana 7
HU - Ungheria 7
IL - Israele 7
JM - Giamaica 7
MY - Malesia 7
PH - Filippine 7
TN - Tunisia 7
LK - Sri Lanka 6
UY - Uruguay 6
AU - Australia 5
BH - Bahrain 5
CR - Costa Rica 5
GR - Grecia 5
MD - Moldavia 5
NP - Nepal 5
OM - Oman 5
SN - Senegal 5
BG - Bulgaria 4
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BB - Barbados 3
BO - Bolivia 3
EU - Europa 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
PA - Panama 3
QA - Qatar 3
TT - Trinidad e Tobago 3
BS - Bahamas 2
DK - Danimarca 2
DZ - Algeria 2
GA - Gabon 2
HR - Croazia 2
LV - Lettonia 2
NO - Norvegia 2
PS - Palestinian Territory 2
TH - Thailandia 2
VA - Santa Sede (Città del Vaticano) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
Totale 15.052
Salva come PNG Salva come JPEG
Città #
Singapore 1.147
Chandler 613
San Jose 591
Ashburn 538
Warsaw 222
Ho Chi Minh City 218
Beijing 195
New York 193
Los Angeles 159
Rome 154
Dublin 150
Hanoi 139
San Mateo 126
Lauterbourg 121
Hefei 118
Ann Arbor 114
Tokyo 113
Jakarta 108
The Dalles 100
São Paulo 97
Jacksonville 96
Fairfield 93
Wilmington 93
Milan 86
Moscow 86
Hong Kong 81
Munich 81
Frankfurt am Main 80
St Louis 76
Boston 74
Dallas 73
Nanjing 68
Helsinki 66
Marseille 62
Seattle 62
Chicago 60
Houston 60
Woodbridge 50
Princeton 49
Bremen 48
Kent 46
Nürnberg 46
Montreal 43
Santa Clara 42
Cattolica 41
Orem 39
Turku 38
Da Nang 35
Dearborn 35
Nuremberg 33
London 32
Zhengzhou 32
Denver 31
Rio de Janeiro 31
Brooklyn 30
Boardman 29
Brussels 28
Council Bluffs 28
Redwood City 28
Cambridge 27
Lawrence 27
Hyderabad 26
Nanchang 25
Buffalo 24
Seoul 24
Mountain View 23
North Bergen 23
Paris 23
Stockholm 22
Atlanta 21
Belo Horizonte 21
University Park 21
Amsterdam 20
Bexley 20
Haiphong 19
Hangzhou 19
Johannesburg 19
Norwalk 19
Phoenix 19
Shanghai 19
Chennai 18
Vienna 17
Baghdad 16
Düsseldorf 16
Mexico City 16
Shenyang 16
Tashkent 16
Trieste 16
Augusta 15
Lappeenranta 15
Mumbai 15
Guangzhou 14
Poplar 14
Tianjin 14
Hebei 13
Kraków 13
Redmond 13
Abidjan 12
Kunming 12
Leawood 12
Totale 8.081
Salva come PNG Salva come JPEG
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 410
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 310
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 307
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 307
Double pituitary adenomas 237
Predictors of morbidity and mortality in acromegaly, an Italian survey. 232
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 214
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 211
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 200
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 199
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 198
Assessment of neurological manifestations in hospitalized patients with COVID-19 195
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 183
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 179
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 171
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 163
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 161
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 157
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 151
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 150
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 149
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 146
The Changing Clinical Spectrum of Hypophysitis 146
Hypothalamitis: a diagnostic and therapeutic challenge 145
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 144
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 142
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 142
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 141
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 141
GH receptor isoforms and skeletal fragility in acromegaly 140
Spontaneous thyroid nodule hemorrhage in the emergency department 135
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 133
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 132
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 131
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 128
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 127
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 125
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 124
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 123
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 123
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 122
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 121
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 121
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 120
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 119
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 118
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 118
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 116
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 116
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 115
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 114
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 114
Empty sella syndrome: Multiple endocrine disorders. 114
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 113
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 112
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 110
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 108
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 108
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 107
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 106
Hypothalamitis and pituitary atrophy 106
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 105
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 105
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 105
High prevalence of hyperplastic colonic polyps in acromegalic subjects 105
Vertebral fractures in patients with acromegaly: a 3-year prospective study 105
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 105
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 105
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 103
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 103
Understanding the effect of acromegaly on the human skeleton. 103
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 103
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 102
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 102
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 101
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 100
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 100
Neuropsychiatric symptoms, oral pigmentation and fever as revealing hints of autoimmune Addison’s disease 98
Diabetic neuropathy: a risk factor for severe COVID-19? 98
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 98
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 97
Vertebral fractures in males with prolactinoma. 97
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 97
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 95
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 94
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 94
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 93
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 93
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 93
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 92
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study 92
Trouillas’s Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 87
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 87
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 87
Acromegaly can be cured by first-line pasireotide treatment? 86
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 85
Systemic mastocytosis mimicking carcinoid syndrome 85
Acromegaly in the elderly patients 84
Second line treatment of acromegaly: Pasireotide or Pegvisomant? 83
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 82
Totale 13.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 93 11
2021/2022774 29 44 10 73 87 34 21 130 26 49 110 161
2022/20231.720 193 228 140 272 101 236 98 142 182 24 65 39
2023/2024919 38 209 33 46 44 150 47 20 33 55 104 140
2024/20252.383 45 52 161 95 139 89 61 94 345 241 494 567
2025/20266.844 919 286 528 1.010 1.118 361 1.130 413 440 571 68 0
Totale 15.373